NCNA today
$0.93+$0.00 (+0.16%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minConsolidating
Daily trend turns up above $1.67
Key levels
Resistance$1.34
Resistance$1.22
Support$0.90
Latest news & SEC filings
EarningsNuCana Posts Q3 2026 Results, Gives Business Update
LegalNuCana Gets European Patent for NUC-7738
All NCNA news →About NuCana
NuCana is a clinical-stage biopharmaceutical company that develops medicines for cancer patients. Its work centers on new chemical entities designed to overcome resistance to existing chemotherapy agents, with a pipeline of product candidates tested in clinical trials. The company operates in the United Kingdom and the United States and is led by a team with backgrounds in oncology drug development.
Based on the company's 20-F filed Mar 19, 2026.
Nasdaq · Healthcare
NuCana plc (NCNA)
What Is the Price Target for NCNA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is NCNA a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NCNA.
Start Free Trial →Is NCNA Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
12
Moat Score
NONE
4/9
Piotroski Score
826.4
Altman Z-Score
What Is Smart Money Doing with NCNA?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NCNA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
100%
FCF Growth YoY
59.7%
Revenue Trend
UNKNOWN
Dark Pool Trades for NCNA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NCNA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:59:23 | $0.94 | 1,800 | $$2K | MIDPOINT |
| 16:56:11 | $0.93 | 1,000 | $$930 | SELL |
| 24:01:50 | $0.93 | 1,000 | $$930 | BUY |
| 24:01:50 | $0.93 | 1,300 | $$1K | BUY |
| 24:01:50 | $0.93 | 1,500 | $$1K | BUY |
5 dark pool trades shown · $$6K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for NuCana plc (NCNA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NCNA — frequently asked questions
What is NCNA stock price today?
NuCana plc (NCNA) is at $0.93, up 0.16% (+$0.00) at the Nov 13, 2026 close.
Why is NCNA stock moving today?
Latest NCNA news — Nov 13, 2026: NuCana Posts Q3 2026 Results, Gives Business Update · Sep 30, 2026: NuCana Gets European Patent for NUC-7738
Did NCNA beat earnings?
NCNA last reported on Aug 13, 2026: EPS -$0.99 vs -$2.65 expected — a beat of 62.7%.
Does NCNA pay a dividend?
NCNA does not currently pay a dividend.
What are NCNA support and resistance levels?
Support: $0.90. Resistance: $1.22, $1.34, $1.49.
What are insiders doing with NCNA?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on NCNA?
Nov 13, 2026: NuCana Posts Q3 2026 Results, Gives Business Update · Sep 30, 2026: NuCana Gets European Patent for NUC-7738